THE WOODLANDS, Texas, Oct. 18, 2017 -- Nexeo Solutions, Inc. (NASDAQ:NXEO) announced they will be the commercial source for Mackstat® and Paragon® Preservatives product line globally. This decision comes as a result of consolidation and rationalization efforts that will help Solvay focus on the continued development of solutions for the Home and Personal care market. All specifications and manufacturing locations remain the same.
"The Mackstat® and Paragon® product line is highly complementary to our product offering as well as our customer base in personal and home care business. We consistently look for ways to improve the value that we bring to our customers," said Joey Gullion, Vice President of Specialty Chemicals at Nexeo Solutions.
About Nexeo Solutions, Inc.
Nexeo Solutions is a leading global chemicals and plastics distributor, representing products from world-class producers to a diverse customer base. From product specification to sustainable solutions, the Company goes beyond traditional logistics to provide value-added services across many industries, including chemicals manufacturing, oil and gas, coatings, personal care, healthcare, automotive and 3D printing. The Company leverages a centralized technology platform to identify efficiencies and create solutions to unlock value for suppliers and customers. Learn more at www.nexeosolutions.com.
FOR FURTHER INFORMATION PLEASE CONTACT
Media Relations, Nexeo Solutions
Tel: +1.281.297.0851, [email protected]
Investor Relations, Nexeo Solutions
Tel: +1.281.297.0856, [email protected]


Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Bain Capital Moves to Acquire Majority Stake in Echo Marketing
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 



